Heart disease is the leading cause of death in the UK, with conditions like coronary artery disease (CAD) often showing no symptoms until it’s too late. This risk isn’t limited to older adults; it can affect anyone, regardless of age or gender. According to the British Heart Foundation and NHS England, cardiovascular disease (CVD) remains one of the leading health challenges in the UK.

The Cardisio Heart Test is revolutionary in its ability to detect heart disease at its earliest stages, especially CAD, long before symptoms become evident. Traditional methods often identify heart conditions only once significant damage has occurred. By utilizing advanced vectorcardiography (VCG) and artificial intelligence technology, Cardisio offers you the chance to protect your heart health proactively.

• Anyone who just wants to be certain their heart is in tip-top condition.
• Anyone who is about to start exercising or join a gym or plan a 5K run or a marathon.
• Those who have a family history of heart disease.
• Those who smoke or are overweight.
• Anyone with diabetes, high blood pressure or cholesterol issues.
• If you experience symptoms such as shortness of breath, fatigue or chest discomfort.

First and foremost, don’t worry.
1. What does a “Visible indications of a possible disorder” result mean?
• Potential signs of heart disease: Visible indications of a possible disorder suggest potential signs of heart disease or dysfunction. This does not confirm a diagnosis but indicates the need for further investigation.
• Test sensitivity: The Cardisio test is very sensitive and can detect very small differences in the electrical activity within your heart. This result indicates visible signs of a possible heart disorder that require further evaluation by a doctor.
• Please do not worry: This result should only be seen as needing urgent follow-up, if you also experience any of the symptoms listed at the end of this section.
• This is not a formal diagnosis: This result does not confirm heart disease but suggests potential risk factors or areas that could benefit from further evaluation.
2. Important recommendations:
• Consult your doctor: Schedule a follow-up appointment with your GP to discuss your results in detail. If you have indicated on the consent form that you are happy for the results to be sent to your GP, the pharmacist will do this.
• Additional tests: Your doctor may recommend additional diagnostic tests, such as blood tests for cardiac markers, or refer you to hospital to see a cardiologist.
3. Managing symptoms:
• If you experience any symptoms listed at the end of this leaflet, please call 111 or if urgent 999.
4. Lifestyle adjustments: While awaiting to see your doctor, adopt these heart-healthy habits:
• Reduce salt, sugar, and unhealthy fats in your diet.
• Avoid any strenuous physical activity.
• Avoid alcohol and tobacco completely, and limit caffeine intake.
5. Emotional well-being: It’s normal to have concerns about these types of results. Take time to discuss them with your doctor.
Your health is our priority. With timely care and the right interventions, many heart conditions can be well-managed. Please reach out with any questions or for further guidance.
(Physical symptoms to be aware of, if you experience any of these please call 111 or if urgent 999)
Classic symptoms of heart disorders, including heart attack, may include chest pain or discomfort, pain radiating to the arms, neck, or jaw, shortness of breath, nausea, or cold sweats. Circulatory disorders like stroke can present with sudden weakness or numbness on one side of the body, difficulty speaking or understanding, dizziness, or a severe headache. Being aware of these symptoms can help ensure timely medical attention.

Yes, even if you have no symptoms, a family history of heart disease increases your risk of developing cardiovascular conditions. Many heart conditions, including coronary artery disease (CAD), progress silently before noticeable symptoms appear.

✔ Early Detection Can Prevent Future Problems – Heart disease often develops over time. Identifying risk early allows for preventative action, potentially avoiding severe complications. ✔ Genetics Play a Major Role – If close relatives have heart disease, your risk is higher, even if you maintain a healthy lifestyle. ✔ Symptoms Can Be Subtle or Absent – Some individuals with significant heart disease experience no warning signs. The Cardisio test provides insights into your heart health even before symptoms develop. ✔ Non-Invasive, Fast, and Accessible – The test is quick, pain-free, and available at select community pharmacies for easy and convenient heart health screening.

Taking a proactive approach to heart health can provide peace of mind and allow for early intervention if needed. The Cardisio Heart Test helps identify potential concerns before they become critical.

The Cardisio Heart Test provides a more accessible and proactive approach to heart health screening, particularly for community pharmacies offering health checks to the general public. Unlike traditional primary care heart checks, which often focus on detecting risk factors (such as blood pressure and cholesterol levels), the Cardisio Heart Test identifies actual heart abnormalities at an early stage.

✔ Advanced Detection Using Vectorcardiography (VCG) and AI Analysis – Unlike standard ECGs, which capture limited heart electrical activity, Cardisio provides a full 3D analysis for precise coronary artery disease (CAD) detection. ✔ Ideal for Preventative Screening in Community Pharmacies – Many GP-led heart checks focus on existing conditions. The Cardisio test allows pharmacies to offer a proactive heart health service, identifying potential issues before symptoms develop. ✔ Quick, Non-Invasive, and Immediate Results – Unlike tests requiring blood samples or hospital visits, Cardisio is pain-free, takes just 4 minutes, and provides instant results. ✔ Improves Accessibility for the Public – Many people find it difficult to access timely cardiac assessments through their GP. By offering the Cardisio Heart Test in pharmacies, communities gain easier access to preventative heart screening.

By incorporating Cardisio into community pharmacy services, individuals benefit from a convenient, fast, and accurate tool for detecting heart disease early, helping to reduce the burden on primary care while improving patient outcomes.

The General Pharmaceutical Council’s (GPhC) “In practice: Guidance on consent” (June 2018) outlines the responsibilities of pharmacy professionals in obtaining valid consent to ensure person-centred care. Consent is defined as a person’s agreement for a healthcare professional to provide care, treatment, or disclose information. It can be explicit (clearly expressed) or implied (inferred from actions), and must be given voluntarily by an individual with the capacity to decide.​assets.pharmacyregulation.org+2assets.pharmacyregulation.org+2assets.pharmacyregulation.org+2

Key Points:

• Capacity Assessment: Pharmacy professionals must assess whether individuals can understand, retain, and weigh information to make informed decisions. If a person lacks capacity, professionals should act in their best interests, considering legal frameworks and consulting with relevant parties.​assets.pharmacyregulation.org

• Adults with Capacity: Competent adults have the right to accept or refuse treatment. Professionals must respect these decisions, even if they disagree, ensuring the individual is informed about the consequences.​

• Children and Young People: Consent considerations vary based on age and maturity. Young people (16-17 years) are generally presumed to have capacity, while children under 16 must demonstrate sufficient understanding to make decisions. Parental involvement is advised, especially when the young person lacks capacity.​

• Advance Decisions and Emergencies: Professionals should respect valid advance decisions made by individuals regarding future treatment preferences. In emergencies, immediate care may proceed without consent if it’s in the person’s best interests.​assets.pharmacyregulation.org

Pharmacy professionals are encouraged to use their judgment, seek advice when uncertain, and ensure all team members understand their responsibilities concerning consent. This guidance aligns with the GPhC’s standards, emphasizing the importance of obtaining consent to provide care and pharmacy services.​

For comprehensive details, refer to the full guidance document:

In the UK the data collected is transmitted over a secure link to the data centre located in the UK. It is the process by advanced Artificial Intellegence based algorythms. The results are then sent back to the test administrator for printing and communication with the patient. The results are also stored on servers in the secure UK Data Centre.